secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001213900-23-097076
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed shareholders elect all director nominees at 2023 AGM
----------------------------------------------------------

- Eric A. Adams re-elected with 76.09% of votes cast; 23.91% withheld.
- All five director nominees (Adams, Hull, Grove, Baldasare, Lemerond) received over 66% support.
- Shareholders approved Marcum LLP as independent auditor with 90.45% of votes cast.
- Total turnout: 1,292,647 shares (38.84% of 3,328,191 outstanding shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/0001213900-23-097076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390023097076/ea190383-8k_inmedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-097076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer